SkinBioTherapeutics plc has appointed both its interim CEO and chair on a permanent basis as it recovers from a crisis earlier this year. The Newcastle firm, developing gut-based products which promote skin health, is showing signs of recovery after also reporting its full-year results. Rachel Parsonage (pictured) has agreed to become permanent CEO while former … Continue reading Recovering crisis firm SkinBioTherapeutics appoints leaders